BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 26350748)

  • 1. Mitochondrial metabolism in cancer stem cells: a therapeutic target for colon cancer.
    Song IS; Jeong YJ; Han J
    BMB Rep; 2015 Oct; 48(10):539-40. PubMed ID: 26350748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FOXM1-Induced PRX3 Regulates Stemness and Survival of Colon Cancer Cells via Maintenance of Mitochondrial Function.
    Song IS; Jeong YJ; Jeong SH; Heo HJ; Kim HK; Bae KB; Park YH; Kim SU; Kim JM; Kim N; Ko KS; Rhee BD; Han J
    Gastroenterology; 2015 Oct; 149(4):1006-16.e9. PubMed ID: 26091938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial biogenesis is required for the anchorage-independent survival and propagation of stem-like cancer cells.
    De Luca A; Fiorillo M; Peiris-Pagès M; Ozsvari B; Smith DL; Sanchez-Alvarez R; Martinez-Outschoorn UE; Cappello AR; Pezzi V; Lisanti MP; Sotgia F
    Oncotarget; 2015 Jun; 6(17):14777-95. PubMed ID: 26087310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of cancer stem cells from human glioblastomas: growth and differentiation capabilities and CD133/prominin-1 expression.
    Gambelli F; Sasdelli F; Manini I; Gambarana C; Oliveri G; Miracco C; Sorrentino V
    Cell Biol Int; 2012 Jan; 36(1):29-38. PubMed ID: 21916848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.
    Botchkina IL; Rowehl RA; Rivadeneira DE; Karpeh MS; Crawford H; Dufour A; Ju J; Wang Y; Leyfman Y; Botchkina GI
    Cancer Genomics Proteomics; 2009; 6(1):19-29. PubMed ID: 19451087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Endothelin-1 and NR4A2 as CD133-regulated genes in colon cancer cells.
    Puglisi MA; Barba M; Corbi M; Errico MF; Giorda E; Saulnier N; Boninsegna A; Piscaglia AC; Carsetti R; Cittadini A; Gasbarrini A; Sgambato A
    J Pathol; 2011 Oct; 225(2):305-14. PubMed ID: 21826669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miRNA expression profile of colon cancer stem cells compared to non-stem cells using the SW1116 cell line.
    Fang Y; Xiang J; Chen Z; Gu X; Li Z; Tang F; Zhou Z
    Oncol Rep; 2012 Dec; 28(6):2115-24. PubMed ID: 23007737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential role of CD133 in immune surveillance and apoptosis: a mitochondrial connection?
    Zobalova R; Prokopova K; Stantic M; Stapelberg M; Dong LF; Ralph SJ; Akporiaye E; Neuzil J
    Antioxid Redox Signal; 2011 Dec; 15(12):2989-3002. PubMed ID: 21504364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial-targeted nitroxides disrupt mitochondrial architecture and inhibit expression of peroxiredoxin 3 and FOXM1 in malignant mesothelioma cells.
    Cunniff B; Benson K; Stumpff J; Newick K; Held P; Taatjes D; Joseph J; Kalyanaraman B; Heintz NH
    J Cell Physiol; 2013 Apr; 228(4):835-45. PubMed ID: 23018647
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional repression of cancer stem cell marker CD133 by tumor suppressor p53.
    Park EK; Lee JC; Park JW; Bang SY; Yi SA; Kim BK; Park JH; Kwon SH; You JS; Nam SW; Cho EJ; Han JW
    Cell Death Dis; 2015 Nov; 6(11):e1964. PubMed ID: 26539911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peroxiredoxin 3 maintains the survival of endometrial cancer stem cells by regulating oxidative stress.
    Song IS; Jeong YJ; Seo YJ; Byun JM; Kim YN; Jeong DH; Han J; Kim KT; Jang SW
    Oncotarget; 2017 Nov; 8(54):92788-92800. PubMed ID: 29190956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein cross-talk in CD133+ colon cancer cells indicates activation of the Wnt pathway and upregulation of SRp20 that is potentially involved in tumorigenicity.
    Corbo C; Orrù S; Gemei M; Noto RD; Mirabelli P; Imperlini E; Ruoppolo M; Vecchio LD; Salvatore F
    Proteomics; 2012 Jun; 12(12):2045-59. PubMed ID: 22623141
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sasa quelpaertensis Leaf Extract Inhibits Colon Cancer by Regulating Cancer Cell Stemness in Vitro and in Vivo.
    Min SJ; Lim JY; Kim HR; Kim SJ; Kim Y
    Int J Mol Sci; 2015 Apr; 16(5):9976-97. PubMed ID: 25941936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copper-64-diacetyl-bis (N4-methylthiosemicarbazone) accumulates in rich regions of CD133+ highly tumorigenic cells in mouse colon carcinoma.
    Yoshii Y; Furukawa T; Kiyono Y; Watanabe R; Waki A; Mori T; Yoshii H; Oh M; Asai T; Okazawa H; Welch MJ; Fujibayashi Y
    Nucl Med Biol; 2010 May; 37(4):395-404. PubMed ID: 20447549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD49f-positive cell population efficiently enriches colon cancer-initiating cells.
    Haraguchi N; Ishii H; Mimori K; Ohta K; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Yamamoto H; Doki Y; Mori M
    Int J Oncol; 2013 Aug; 43(2):425-30. PubMed ID: 23708747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. STAT3 signaling pathway is necessary for cell survival and tumorsphere forming capacity in ALDH⁺/CD133⁺ stem cell-like human colon cancer cells.
    Lin L; Fuchs J; Li C; Olson V; Bekaii-Saab T; Lin J
    Biochem Biophys Res Commun; 2011 Dec; 416(3-4):246-51. PubMed ID: 22074823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting signal transducer and activator of transcription 3 pathway by cucurbitacin I diminishes self-renewing and radiochemoresistant abilities in thyroid cancer-derived CD133+ cells.
    Tseng LM; Huang PI; Chen YR; Chen YC; Chou YC; Chen YW; Chang YL; Hsu HS; Lan YT; Chen KH; Chi CW; Chiou SH; Yang DM; Lee CH
    J Pharmacol Exp Ther; 2012 May; 341(2):410-23. PubMed ID: 22328572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer.
    Horst D; Scheel SK; Liebmann S; Neumann J; Maatz S; Kirchner T; Jung A
    J Pathol; 2009 Dec; 219(4):427-34. PubMed ID: 19621338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The AC133 epitope, but not the CD133 protein, is lost upon cancer stem cell differentiation.
    Kemper K; Sprick MR; de Bree M; Scopelliti A; Vermeulen L; Hoek M; Zeilstra J; Pals ST; Mehmet H; Stassi G; Medema JP
    Cancer Res; 2010 Jan; 70(2):719-29. PubMed ID: 20068153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytometric profiling of CD133+ cells in human colon 
carcinoma cell lines identifies a common core phenotype 
and cell type-specific mosaics.
    Gemei M; Di Noto R; Mirabelli P; Del Vecchio L
    Int J Biol Markers; 2013 Sep; 28(3):267-73. PubMed ID: 23709346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.